N-[(3R,6S,9R,12S,19S,21R)-21-hydroxy-6-(1H-indol-3-ylmethyl)-9-methyl-3-(2-methylpropyl)-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-2-(2-oxopyrrolidin-1-yl)acetamide

C37H52N8O8 — CID 135098445

IUPACN-[(3R,6S,9R,12S,19S,21R)-21-hydroxy-6-(1H-indol-3-ylmethyl)-9-methyl-3-(2-methylpropyl)-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-2-(2-oxopyrrolidin-1-yl)acetamide
SMILESCC(C)C[C@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](C)NC(=O)[C@@H](NC(=O)CN2CCCC2=O)CCCCNC(=O)[C@@H]2C[C@@H](O)CN2C1=O
InChIInChI=1S/C37H52N8O8/c1-21(2)15-29-37(53)45-19-24(46)17-30(45)36(52)38-13-7-6-11-27(41-31(47)20-44-14-8-12-32(44)48)34(50)40-22(3)33(49)42-28(35(51)43-29)16-23-18-39-26-10-5-4-9-25(23)26/h4-5,9-10,18,21-22,24,27-30,39,46H,6-8,11-17,19-20H2,1-3H3,(H,38,52)(H,40,50)(H,41,47)(H,42,49)(H,43,51)/t22-,24-,27+,28+,29-,30+/m1/s1
InChIKeyPVVXFDLMHOAWPK-BSYFPZJBSA-N
MW736.87 g/mol
LogP-0.40
Rot. Bonds7

About N-[(3R,6S,9R,12S,19S,21R)-21-hydroxy-6-(1H-indol-3-ylmethyl)-9-methyl-3-(2-methylpropyl)-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-2-(2-oxopyrrolidin-1-yl)acetamide

N-[(3R,6S,9R,12S,19S,21R)-21-hydroxy-6-(1H-indol-3-ylmethyl)-9-methyl-3-(2-methylpropyl)-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-2-(2-oxopyrrolidin-1-yl)acetamide (PubChem CID 135098445) has the molecular formula C37H52N8O8 and a molecular weight of 736.87 g/mol. Its IUPAC name is N-[(3R,6S,9R,12S,19S,21R)-21-hydroxy-6-(1H-indol-3-ylmethyl)-9-methyl-3-(2-methylpropyl)-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-2-(2-oxopyrrolidin-1-yl)acetamide.

Molecular Properties

Compound NameN-[(3R,6S,9R,12S,19S,21R)-21-hydroxy-6-(1H-indol-3-ylmethyl)-9-methyl-3-(2-methylpropyl)-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-2-(2-oxopyrrolidin-1-yl)acetamide
PubChem CID135098445
Molecular FormulaC37H52N8O8
Molecular Weight736.87 g/mol
Exact Mass736.39
IUPAC NameN-[(3R,6S,9R,12S,19S,21R)-21-hydroxy-6-(1H-indol-3-ylmethyl)-9-methyl-3-(2-methylpropyl)-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-2-(2-oxopyrrolidin-1-yl)acetamide
SMILESCC(C)C[C@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](C)NC(=O)[C@@H](NC(=O)CN2CCCC2=O)CCCCNC(=O)[C@@H]2C[C@@H](O)CN2C1=O
InChIInChI=1S/C37H52N8O8/c1-21(2)15-29-37(53)45-19-24(46)17-30(45)36(52)38-13-7-6-11-27(41-31(47)20-44-14-8-12-32(44)48)34(50)40-22(3)33(49)42-28(35(51)43-29)16-23-18-39-26-10-5-4-9-25(23)26/h4-5,9-10,18,21-22,24,27-30,39,46H,6-8,11-17,19-20H2,1-3H3,(H,38,52)(H,40,50)(H,41,47)(H,42,49)(H,43,51)/t22-,24-,27+,28+,29-,30+/m1/s1
InChIKeyPVVXFDLMHOAWPK-BSYFPZJBSA-N
XLogP-0.40
TPSA222.14 Ų
H-Bond Donors7
H-Bond Acceptors8
Rotatable Bonds7
Heavy Atoms53
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500736.87
LogP ≤ 5-0.40
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 108

Analyze N-[(3R,6S,9R,12S,19S,21R)-21-hydroxy-6-(1H-indol-3-ylmethyl)-9-methyl-3-(2-methylpropyl)-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-2-(2-oxopyrrolidin-1-yl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(3R,6S,9R,12S,19S,21R)-21-hydroxy-6-(1H-indol-3-ylmethyl)-9-methyl-3-(2-methylpropyl)-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-2-(2-oxopyrrolidin-1-yl)acetamide?
The IUPAC name of N-[(3R,6S,9R,12S,19S,21R)-21-hydroxy-6-(1H-indol-3-ylmethyl)-9-methyl-3-(2-methylpropyl)-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-2-(2-oxopyrrolidin-1-yl)acetamide (CID 135098445) is N-[(3R,6S,9R,12S,19S,21R)-21-hydroxy-6-(1H-indol-3-ylmethyl)-9-methyl-3-(2-methylpropyl)-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-2-(2-oxopyrrolidin-1-yl)acetamide.
What is the SMILES notation for N-[(3R,6S,9R,12S,19S,21R)-21-hydroxy-6-(1H-indol-3-ylmethyl)-9-methyl-3-(2-methylpropyl)-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-2-(2-oxopyrrolidin-1-yl)acetamide?
The canonical SMILES for N-[(3R,6S,9R,12S,19S,21R)-21-hydroxy-6-(1H-indol-3-ylmethyl)-9-methyl-3-(2-methylpropyl)-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-2-(2-oxopyrrolidin-1-yl)acetamide is CC(C)C[C@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](C)NC(=O)[C@@H](NC(=O)CN2CCCC2=O)CCCCNC(=O)[C@@H]2C[C@@H](O)CN2C1=O.
What is the InChIKey of N-[(3R,6S,9R,12S,19S,21R)-21-hydroxy-6-(1H-indol-3-ylmethyl)-9-methyl-3-(2-methylpropyl)-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-2-(2-oxopyrrolidin-1-yl)acetamide?
The InChIKey is PVVXFDLMHOAWPK-BSYFPZJBSA-N. The full InChI is InChI=1S/C37H52N8O8/c1-21(2)15-29-37(53)45-19-24(46)17-30(45)36(52)38-13-7-6-11-27(41-31(47)20-44-14-8-12-32(44)48)34(50)40-22(3)33(49)42-28(35(51)43-29)16-23-18-39-26-10-5-4-9-25(23)26/h4-5,9-10,18,21-22,24,27-30,39,46H,6-8,11-17,19-20H2,1-3H3,(H,38,52)(H,40,50)(H,41,47)(H,42,49)(H,43,51)/t22-,24-,27+,28+,29-,30+/m1/s1.
What are the key properties of N-[(3R,6S,9R,12S,19S,21R)-21-hydroxy-6-(1H-indol-3-ylmethyl)-9-methyl-3-(2-methylpropyl)-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-2-(2-oxopyrrolidin-1-yl)acetamide?
N-[(3R,6S,9R,12S,19S,21R)-21-hydroxy-6-(1H-indol-3-ylmethyl)-9-methyl-3-(2-methylpropyl)-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-2-(2-oxopyrrolidin-1-yl)acetamide has a molecular weight of 736.87 g/mol, XLogP of -0.40, 7 rotatable bonds, 7 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3R,6S,9R,12S,19S,21R)-21-hydroxy-6-(1H-indol-3-ylmethyl)-9-methyl-3-(2-methylpropyl)-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-2-(2-oxopyrrolidin-1-yl)acetamide is sourced from PubChem (CID 135098445), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).